Professor Yoshiaki Omura's far-reaching expertise is rooted in a strong academic background involving an unusual combination of fields including experimental physics, medical electronics, and basic and clinical medicine from both Western and Oriental perspectives. Professor Yoshiaki Omura, MD, ScD, is a cardiologist with a remarkable 50 year career in the medical world. He serves as President of the International College of Acupuncture & Electro-Therapeutics, Adjunct Professor at the Department of Family & Community Medicine of New York Medical College since 2008, Editor-in-Chief of Acupuncture & Electro-Therapeutics Research, International Journal of Integrated Medicine since 1974, and Director of Medical Research of Heart Disease Research Foundation from 1972 to 2016. He received his B.Sc in Applied Physics at Waseda University Tokyo & M.D. at the Yokohama City University in Japan and trained first at Tokyo University & graduated from Columbia University where he received Cardiovascular Fellowship & Resident Training in Oncological Surgery & his degree of Sc.D. in Pharmaco-Electrophysiology of Single Cardiac Cells in Vivo & in Vitro. Professor Yoshiaki Omura is a specialist in cardiology, oncology, acupuncture & electro-therapeutics and basic & clinical research in these fields. He is a Life Fellow of the Royal Society of Medicine (England), the American College of Acupuncture, and the American Association of Integrative Medicine, as well as Fellow of the International College of Acupuncture and Electro-therapeutics. He published over 270 original research reports and 9 books. Formerly Maitre de Recherche at INSERM (National Institute of Health & Medical Research) of French Government; formerly visiting Prof. of Psychophysiology at University of Paris (No. 4) & visiting Prof. & Research Consultant of Electro-anesthesia & Neuroelectricity at University of Rene Descartes of University of Paris (No. 5); visiting Research Prof. of Electrical Engineering Dept. at Manhattan College; formerly Adjunct Prof. of Pharmacology at Chicago Medical School; visiting Prof. of Anesthesiology Dept. at University of Padua, Italy; formerly Adjunct Prof. of Physiology at Showa University Medical School, Tokyo; formerly Prof. of Non-orthodox Medicine at Ukrainian Kiev National Medical University, and visiting Prof. at Ningxia University Medical School, China. Professor Omura teaches or gives consultations through the activity of his associated organizations and by request of other doctors and medical organizations. He is Life Fellow of: The Royal society of Medicine (England), American College of Acupuncture, American Association of Integrative Medicine, Fellow and President of the International College of Acupuncture and Electrotherapeutics. Professor Omura has done extensive research on the effects of chemotherapy on the heart and brain of cancer patients since he noticed many cancer patients developed memory problems and complain of heaviness in chest or mild chest pain after chemotherapy. While most ECGs do not show any significant changes by chemotherapy, he found significant biochemical changes in specific part of the rising part of the T-waves without significant visible changes in ECGs. He also developed a method to identify any infection of any part of the heart from ECG, and he is the first one to report in late 1990s that repeated Acupuncture treatment of Lyme Disease infected joint pain is one of the significant unrecognized causes of atrial flutters and atrial fibrillations by spreading of Lyme disease's Spirocheta by rupturing capillaries of Borrelia Burgdorferi infected painful joints. Recently he succeeded in developing a new method of screening cancers from
Dr Sergey Suchkov, MD, PhD. Professor in Immunology & Medicine. Personal: Born 11 January 1957, Astrakhan, Russia. divorced; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, 1985; Doctor Degree, National Institute of Immunology, Russia, 2001. Positions held: Post Doc Research Associate, Institute of Medical Enzymology, 1985-87; Senior Research Associate, Koltzov Institute of Developmental Biology, USSR Academy of Sciences, 1987-89; Head of the Lab of Immunology and Immunobiotechnology, Helmholtz Eye Research Institute in Moscow, 1989-95; Trainee, Laboratory of Immunology, NEI, Bethesda, MD, USA, NIH and Laboratory of Immunology, Wills Eye Hospital, Philadelphia, USA, as well as at some of the British Universities on the invitation of the Royal Society for Immunology, 1989; Chairman, Department for Clinical Immunology, Moscow Clinical Research Institute and the Immunologist-in-Chief of the Moscow Regional Ministry of Health, 1995-2004; Executive Secretary-in-Chief of the Editorial Board, Biomedical Science International journal, 1993-1996; Professor in Medicine and Immunology, I.M. Sechenov First Moscow Medical University and Faculty Chairman & Director of the Department of Preventive, Personalized and Translational Medicine, A.I.Evdokimov Moscow State University of Medicine & Dentistry. Honours: Secretary General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; European Association for Predictive, Preventive and Personalized Medicine, Brussels; American Association for Research in Vision and Ophthalmology; International Society for Eye Research; EPMA Journal, Personalized Medicine Universe, Open J.Autoimmunity and American J.Cardiovascular Res. Editorial Boards; All-Union (from 1992 - Russian) Biochemical Society; All-Union (from 1992 - Russian) Immunological Society.
Dr. Alvaro Macieira-Coelho is a Research Director at the French National Institute of Health. He received an MD from the University of Lisbon, Portugal, and a PhD from the University of Uppsala Sweden. He made an internship at the University Hospital in Lisbon and was a research associate at the Wistar Institute in Philadelphia (USA) and at the Department of Cell Biology of the University of Uppsala (Sweden). He became Head of the Department of Cell Pathology at the Cancer Institute in Villejuif (France) and was a visiting Professor at the University of Linkoping (Sweden). He published 150 papers in professional Journals and 9 books on cancer and aging. He received the following awards: Fritz Verzar Prize (University of Vienna, Austria), “Seeds of Science”, Career Prize (Lisbon, Portugal), Dr. Honoris Causa (University of Linkoping, Sweden), Johananof International Visiting Professor (Institute Mario Negri, Milano, Italy).
Michael Retsky (PhD in Physics from University of Chicago) made a career change to cancer research thirty years ago. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. Retsky is Editor with Romano Demicheli of a Springer-Nature book published July 2017 (Perioperative Inflammation as Triggering Origin of Metastasis Development). After diagnosis of stage IIIc colon cancer in 1994, he was the first person to use what is now called metronomic chemotherapy. He is a founder and was on the Board of Directors of the Colon Cancer Alliance.
DR. ALAIN L. FYMAT, PhD, he is a medical-physical scientist and an educator. He is the current President/CEO and Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science. He is also Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a frequent Keynote Speaker and International Organizing Committee Member of several international scientific conferences. He has lectured extensively in the U.S., Europe, Asia and Africa. He has published ~ 425 scholarly scientific publications and books. He is also Editor-in-Chief, Honorable Editor or Editor of 62 medical/scientific Journals. Dr. Fymat is a Board member of several institutions, a member of the New York Academy of Sciences and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO. His current research interests are focused on nanomedicine, precision/personalized medicine, neurodegenerative diseases (including Alzheimer, Parkinson, epilepsy, dementias) with many open literature contributions in these several areas.
Interface between science and medicine, particularly nanomedicine, nanobiotechnology, cancer/oncology, molecular/personal/precision medicine, human genetics/ epigenetics/ ecogenetics, neurodegenerative diseases, and pharmacogenomics, nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery across the brain protective barriers, and neurodegenerative disorders (epilepsy, Parkinson's and Alzheimer's diseases).
Professor Beebe is a Research Professor in the Frank Reidy Research Center for Bioelectrics at Old Dominion University (ODU). He received his PhD in Medical Sciences (Pharmacology) at the University of Toledo College of Medicine in 1982 and was a post-doctoral fellow at the Howard Hughes Medical Institute, Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine. He was a Fulbright and Marshall Scholar in Oslo, Norway. He is the author of 125 peer reviewed manuscripts and books chapters. He was awarded two NIH grants analyzing structure and function of Protein Kinase A and cAMP signal transduction. He now investigates mechanisms of NanoPulse Stimulation (NPS) in cancer and biology. He has trained over 30 graduate students and post-doctoral fellows, is a member of Editorial Boards for four journals and is the Chair of the ODU Institutional Animal Care and Use Committee (IACUC).
NanoPulse Stimulation (NPS) in cancer & Immuno-Oncology Applications